Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EOS Health vs Zealthy

EOS Health
Graded #269

Higher grade

vs+16.099999999999994
Zealthy
Graded #496

Lower grade

The verdict

EOS Health takes it — 62.8/100 to 46.7/100.

EOS Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EOS Health is a multi-vertical online telehealth service (weight loss, longevity, men's/women's health, skincare) offering compounded GLP-1 programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEOS Health +18
44
26
Dose & formulationEven
64
64
Clinical oversightEOS Health +46
87
41
Labs & monitoringEOS Health +13
66
53
FulfillmentEOS Health +18
84
66
Contract termsZealthy +21
20
41
EOS Health · left barZealthy · right bar

The numbers

MetricEOS HealthZealthy
WeighScore62.8/10046.7/100
GradeCC
Scorecard rank#269#496
Semaglutide$199/mo (compounded)$286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$289/mo (compounded)$351/mo (starting dose, plus a separate fee, compounded)
Coverage40 states34 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
EOS Health

Graded #269 · C

Strengths

  • Unusually transparent: publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's)
  • Competitive compounded pricing from $199/mo semaglutide and $289/mo tirzepatide, plus $100 off the first prescription with code WELCOME100
  • Multiple compounded formulas (semaglutide, semaglutide+glycine, semaglutide+B12, tirzepatide) and optional 130+ biomarker lab add-ons
  • Free expedited shipping, no insurance required, 10-minute intake, and an ongoing care team via patient portal

Where it loses points

  • Available in only 40 states — not offered in CA, NV, NJ, SC, TX, MA, MS, NH, WV, or DE (pharmacy partner is unlicensed there)
  • Headline prices are 'best rate' figures; standard monthly plans may cost more than the quarterly-plan rate shown
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path
  • Pharmacy partner's page notes it 'cannot dispense sterile compounds,' which is worth confirming for injectable GLP-1 fulfillment
Zealthy

Graded #496 · C

Strengths

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Where it loses points

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard